Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study

[1]  ScienceOpen Admin Advances in Autism , 2017 .

[2]  Amanda K Montoya,et al.  Two-condition within-participant statistical mediation analysis: A path-analytic framework. , 2017, Psychological methods.

[3]  R. Findling,et al.  An update on pharmacotherapy for autism spectrum disorder in children and adolescents , 2015, Current opinion in psychiatry.

[4]  B. Leiby,et al.  Autonomic Dysregulation During Sensory Stimulation in Children with Autism Spectrum Disorder , 2015, Journal of autism and developmental disorders.

[5]  Judith S Miller,et al.  Brief measures of anxiety in non-treatment-seeking youth with autism spectrum disorder , 2015, Autism : the international journal of research and practice.

[6]  J. Herrington,et al.  Brief Report: Emotion Regulation and Respiratory Sinus Arrhythmia in Autism Spectrum Disorder , 2014, Journal of autism and developmental disorders.

[7]  Amanda J. Moffitt,et al.  Effect of propranolol on facial scanning in autism spectrum disorder: A preliminary investigation , 2014, Journal of clinical and experimental neuropsychology.

[8]  R. Bernier,et al.  Brief Report: Social Skills, Internalizing and Externalizing Symptoms, and Respiratory Sinus Arrhythmia in Autism , 2014, Journal of autism and developmental disorders.

[9]  John O. Willis,et al.  Wechsler Abbreviated Scale of Intelligence , 2014 .

[10]  M. Bear,et al.  STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study , 2013, Journal of Autism and Developmental Disorders.

[11]  M. Dadds,et al.  Nasal Oxytocin for Social Deficits in Childhood Autism: A Randomized Controlled Trial , 2013, Journal of Autism and Developmental Disorders.

[12]  Janet B W Williams Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[13]  A. Thurm,et al.  Pharmacotherapy for the Core Symptoms in Autistic Disorder: Current Status of the Research , 2013, Drugs.

[14]  Angela Scarpa,et al.  Respiratory sinus arrhythmia: a marker for positive social functioning and receptive language skills in children with autism spectrum disorders. , 2013, Developmental psychobiology.

[15]  J. Stichter,et al.  A Preliminary Examination of a General Social Outcome Measure , 2012 .

[16]  Kimberly E. Bodner,et al.  Noradrenergic Moderation of Working Memory Impairments in Adults with Autism Spectrum Disorder , 2012, Journal of the International Neuropsychological Society.

[17]  Gregory F. Lewis,et al.  Statistical strategies to quantify respiratory sinus arrhythmia: Are commonly used metrics equivalent? , 2012, Biological Psychology.

[18]  Kimberly E. Bodner,et al.  Effect of Propranolol on Word Fluency in Autism , 2011, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[19]  V. Gaus Adult Asperger Syndrome and the Utility of Cognitive-Behavioral Therapy , 2011, Journal of Contemporary Psychotherapy.

[20]  P. Schmalbrock,et al.  Effect of Propranolol on Functional Connectivity in Autism Spectrum Disorder—A Pilot Study , 2010, Brain Imaging and Behavior.

[21]  S. Porges,et al.  Emotion Recognition in Children with Autism Spectrum Disorders: Relations to Eye Gaze and Autonomic State , 2010, Journal of autism and developmental disorders.

[22]  D. Beversdorf,et al.  Effect of propranolol on verbal problem solving in autism spectrum disorder , 2008, Neurocase.

[23]  Keri J. Heilman,et al.  Physiological responses to social and physical challenges in children: Quantifying mechanisms supporting social engagement and mobilization behaviors. , 2008, Developmental psychobiology.

[24]  Alinda Gillott,et al.  Levels of anxiety and sources of stress in adults with autism , 2007, Journal of intellectual disabilities : JOID.

[25]  C. Johnson,et al.  Management of Children With Autism Spectrum Disorders , 2007, Pediatrics.

[26]  M. Dawson,et al.  The electrodermal system , 2007 .

[27]  Evdokia Anagnostou,et al.  Oxytocin Increases Retention of Social Cognition in Autism , 2007, Biological Psychiatry.

[28]  C. McDougle,et al.  A retrospective study of memantine in children and adolescents with pervasive developmental disorders , 2007, Psychopharmacology.

[29]  S. Porges The polyvagal perspective , 2007, Biological Psychology.

[30]  Xue Ming,et al.  Reduced cardiac parasympathetic activity in children with autism , 2005, Brain and Development.

[31]  Scott Bellini Social Skill Deficits and Anxiety in High-Functioning Adolescents With Autism Spectrum Disorders , 2004 .

[32]  V. Ramachandran,et al.  Autonomic responses of autistic children to people and objects , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[33]  A. Gillott,et al.  Anxiety in High-Functioning Children with Autism , 2001, Autism : the international journal of research and practice.

[34]  D. A. Kenny,et al.  Estimating and testing mediation and moderation in within-subject designs. , 2001, Psychological methods.

[35]  F. Volkmar Pharmacological Interventions in Autism: Theoretical and Practical Issues , 2001, Journal of clinical child psychology.

[36]  P. Rizzon,et al.  Beta-blocker effects on respiratory sinus arrhythmia and baroreflex gain in normal subjects. , 1998, Chest.

[37]  S. Spence,et al.  A measure of anxiety symptoms among children. , 1998, Behaviour research and therapy.

[38]  D. Cohen,et al.  Plasma β-endorphin, adrenocorticotropin hormone, and cortisol in autism , 1997 .

[39]  M. Hasselmo,et al.  Noradrenergic suppression of synaptic transmission may influence cortical signal-to-noise ratio. , 1997, Journal of neurophysiology.

[40]  S. Porges Cardiac vagal tone: A physiological index of stress , 1995, Neuroscience & Biobehavioral Reviews.

[41]  A. Couteur,et al.  Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders , 1994, Journal of autism and developmental disorders.

[42]  F. Volkmar,et al.  Noradrenergic and adrenergic functioning in autism , 1994, Biological Psychiatry.

[43]  J. Cacioppo,et al.  Respiratory sinus arrhythmia: autonomic origins, physiological mechanisms, and psychophysiological implications. , 1993, Psychophysiology.

[44]  V. K. Jensen,et al.  "The effect of beta blockade on stress-induced cognitive dysfunction in adolescents". , 1991, Clinical pediatrics.

[45]  S. Porges,et al.  The analysis of periodic processes in psychophysiological research , 1989 .

[46]  A. Beck,et al.  An inventory for measuring clinical anxiety: psychometric properties. , 1988, Journal of consulting and clinical psychology.

[47]  M. Lader Beta-adrenoceptor antagonists in neuropsychiatry: an update. , 1988, The Journal of clinical psychiatry.

[48]  J. Bemporad,et al.  Brief report: Open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults , 1987, Journal of autism and developmental disorders.

[49]  J. Fermanian,et al.  Catecholamines metabolism in infantile autism: A controlled study of 22 autistic children , 1987, Journal of autism and developmental disorders.

[50]  D. Charney,et al.  Neurobiological mechanisms in human anxiety evidence supporting central noradrenergic hyperactivity , 1983, Neuropharmacology.

[51]  Margaret A. Chesney,et al.  Epinephrine and Norepinephrine Responses in Continuously Collected Human Plasma to a Series of Stressors , 1983, Psychosomatic medicine.

[52]  D. Murphy,et al.  Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. , 1977, Archives of general psychiatry.

[53]  S. Porges The vagus: A mediator of behavioral and physiologic features associated with autism. , 2004 .

[54]  B. Leventhal,et al.  Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. , 1990, The Journal of neuropsychiatry and clinical neurosciences.

[55]  J. Cacioppo,et al.  Principles of psychophysiology : physical, social, and inferential elements , 1990 .

[56]  B. Pitt Psychopharmacology , 1968, Mental Health.